nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—UGT1A1—Mycophenolic acid—psoriasis	0.304	0.451	CbGbCtD
Naltrexone—UGT1A1—Mycophenolate mofetil—psoriasis	0.17	0.252	CbGbCtD
Naltrexone—ABCB1—Mycophenolate mofetil—psoriasis	0.0337	0.0499	CbGbCtD
Naltrexone—ABCB1—Betamethasone—psoriasis	0.0289	0.0428	CbGbCtD
Naltrexone—ABCB1—Prednisolone—psoriasis	0.0285	0.0423	CbGbCtD
Naltrexone—ABCB1—Hydrocortisone—psoriasis	0.027	0.0401	CbGbCtD
Naltrexone—ABCB1—Prednisone—psoriasis	0.0269	0.0399	CbGbCtD
Naltrexone—ABCB1—Cyclosporine—psoriasis	0.0255	0.0378	CbGbCtD
Naltrexone—ABCB1—Dexamethasone—psoriasis	0.0168	0.0249	CbGbCtD
Naltrexone—ABCB1—Methotrexate—psoriasis	0.0135	0.02	CbGbCtD
Naltrexone—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.00012	0.000368	CcSEcCtD
Naltrexone—Hyperhidrosis—Triamcinolone—psoriasis	0.00012	0.000368	CcSEcCtD
Naltrexone—Convulsion—Betamethasone—psoriasis	0.00012	0.000367	CcSEcCtD
Naltrexone—Convulsion—Dexamethasone—psoriasis	0.00012	0.000367	CcSEcCtD
Naltrexone—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000119	0.000366	CcSEcCtD
Naltrexone—Insomnia—Hydrocortisone—psoriasis	0.000119	0.000366	CcSEcCtD
Naltrexone—Hypertension—Dexamethasone—psoriasis	0.000119	0.000365	CcSEcCtD
Naltrexone—Hypertension—Betamethasone—psoriasis	0.000119	0.000365	CcSEcCtD
Naltrexone—Paraesthesia—Hydrocortisone—psoriasis	0.000118	0.000363	CcSEcCtD
Naltrexone—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000118	0.000363	CcSEcCtD
Naltrexone—Urticaria—Cyclosporine—psoriasis	0.000118	0.000361	CcSEcCtD
Naltrexone—Myalgia—Dexamethasone—psoriasis	0.000117	0.00036	CcSEcCtD
Naltrexone—Myalgia—Betamethasone—psoriasis	0.000117	0.00036	CcSEcCtD
Naltrexone—Abdominal pain—Cyclosporine—psoriasis	0.000117	0.00036	CcSEcCtD
Naltrexone—Body temperature increased—Cyclosporine—psoriasis	0.000117	0.00036	CcSEcCtD
Naltrexone—Anxiety—Dexamethasone—psoriasis	0.000117	0.000359	CcSEcCtD
Naltrexone—Anxiety—Betamethasone—psoriasis	0.000117	0.000359	CcSEcCtD
Naltrexone—Vomiting—Mycophenolic acid—psoriasis	0.000117	0.000358	CcSEcCtD
Naltrexone—Discomfort—Dexamethasone—psoriasis	0.000116	0.000356	CcSEcCtD
Naltrexone—Discomfort—Betamethasone—psoriasis	0.000116	0.000356	CcSEcCtD
Naltrexone—Rash—Mycophenolic acid—psoriasis	0.000116	0.000355	CcSEcCtD
Naltrexone—Dermatitis—Mycophenolic acid—psoriasis	0.000115	0.000354	CcSEcCtD
Naltrexone—Pain—Prednisolone—psoriasis	0.000115	0.000354	CcSEcCtD
Naltrexone—Hepatitis—Methotrexate—psoriasis	0.000115	0.000354	CcSEcCtD
Naltrexone—Urticaria—Mycophenolate mofetil—psoriasis	0.000115	0.000353	CcSEcCtD
Naltrexone—Headache—Mycophenolic acid—psoriasis	0.000115	0.000352	CcSEcCtD
Naltrexone—Decreased appetite—Hydrocortisone—psoriasis	0.000115	0.000351	CcSEcCtD
Naltrexone—Pharyngitis—Methotrexate—psoriasis	0.000114	0.000351	CcSEcCtD
Naltrexone—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000114	0.000351	CcSEcCtD
Naltrexone—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000114	0.000351	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000114	0.000349	CcSEcCtD
Naltrexone—Fatigue—Hydrocortisone—psoriasis	0.000114	0.000349	CcSEcCtD
Naltrexone—Vision blurred—Prednisone—psoriasis	0.000113	0.000347	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000113	0.000347	CcSEcCtD
Naltrexone—Pain—Hydrocortisone—psoriasis	0.000113	0.000346	CcSEcCtD
Naltrexone—Anaphylactic shock—Betamethasone—psoriasis	0.000113	0.000345	CcSEcCtD
Naltrexone—Oedema—Dexamethasone—psoriasis	0.000113	0.000345	CcSEcCtD
Naltrexone—Oedema—Betamethasone—psoriasis	0.000113	0.000345	CcSEcCtD
Naltrexone—Anaphylactic shock—Dexamethasone—psoriasis	0.000113	0.000345	CcSEcCtD
Naltrexone—Insomnia—Triamcinolone—psoriasis	0.000112	0.000344	CcSEcCtD
Naltrexone—Infection—Dexamethasone—psoriasis	0.000112	0.000343	CcSEcCtD
Naltrexone—Infection—Betamethasone—psoriasis	0.000112	0.000343	CcSEcCtD
Naltrexone—Ill-defined disorder—Prednisone—psoriasis	0.000111	0.000342	CcSEcCtD
Naltrexone—Paraesthesia—Triamcinolone—psoriasis	0.000111	0.000342	CcSEcCtD
Naltrexone—Feeling abnormal—Prednisolone—psoriasis	0.000111	0.000341	CcSEcCtD
Naltrexone—Shock—Betamethasone—psoriasis	0.000111	0.00034	CcSEcCtD
Naltrexone—Shock—Dexamethasone—psoriasis	0.000111	0.00034	CcSEcCtD
Naltrexone—Dyspnoea—Triamcinolone—psoriasis	0.000111	0.000339	CcSEcCtD
Naltrexone—Nervous system disorder—Dexamethasone—psoriasis	0.00011	0.000339	CcSEcCtD
Naltrexone—Nervous system disorder—Betamethasone—psoriasis	0.00011	0.000339	CcSEcCtD
Naltrexone—Agitation—Prednisone—psoriasis	0.00011	0.000339	CcSEcCtD
Naltrexone—Tachycardia—Betamethasone—psoriasis	0.00011	0.000337	CcSEcCtD
Naltrexone—Tachycardia—Dexamethasone—psoriasis	0.00011	0.000337	CcSEcCtD
Naltrexone—Angioedema—Prednisone—psoriasis	0.00011	0.000337	CcSEcCtD
Naltrexone—Hypersensitivity—Cyclosporine—psoriasis	0.000109	0.000335	CcSEcCtD
Naltrexone—Nausea—Mycophenolic acid—psoriasis	0.000109	0.000334	CcSEcCtD
Naltrexone—Hyperhidrosis—Dexamethasone—psoriasis	0.000109	0.000334	CcSEcCtD
Naltrexone—Hyperhidrosis—Betamethasone—psoriasis	0.000109	0.000334	CcSEcCtD
Naltrexone—Feeling abnormal—Hydrocortisone—psoriasis	0.000109	0.000333	CcSEcCtD
Naltrexone—Malaise—Prednisone—psoriasis	0.000108	0.000332	CcSEcCtD
Naltrexone—Eye disorder—Methotrexate—psoriasis	0.000108	0.000331	CcSEcCtD
Naltrexone—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000108	0.000331	CcSEcCtD
Naltrexone—Syncope—Prednisone—psoriasis	0.000108	0.000331	CcSEcCtD
Naltrexone—Tinnitus—Methotrexate—psoriasis	0.000108	0.00033	CcSEcCtD
Naltrexone—Anorexia—Dexamethasone—psoriasis	0.000107	0.000329	CcSEcCtD
Naltrexone—Anorexia—Betamethasone—psoriasis	0.000107	0.000329	CcSEcCtD
Naltrexone—Urticaria—Prednisolone—psoriasis	0.000107	0.000329	CcSEcCtD
Naltrexone—Cardiac disorder—Methotrexate—psoriasis	0.000107	0.000328	CcSEcCtD
Naltrexone—Fatigue—Triamcinolone—psoriasis	0.000107	0.000328	CcSEcCtD
Naltrexone—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000107	0.000327	CcSEcCtD
Naltrexone—Asthenia—Cyclosporine—psoriasis	0.000106	0.000326	CcSEcCtD
Naltrexone—Pain—Triamcinolone—psoriasis	0.000106	0.000326	CcSEcCtD
Naltrexone—Loss of consciousness—Prednisone—psoriasis	0.000106	0.000324	CcSEcCtD
Naltrexone—Pruritus—Cyclosporine—psoriasis	0.000105	0.000322	CcSEcCtD
Naltrexone—Urticaria—Hydrocortisone—psoriasis	0.000105	0.000321	CcSEcCtD
Naltrexone—Angiopathy—Methotrexate—psoriasis	0.000105	0.000321	CcSEcCtD
Naltrexone—Immune system disorder—Methotrexate—psoriasis	0.000104	0.00032	CcSEcCtD
Naltrexone—Abdominal pain—Hydrocortisone—psoriasis	0.000104	0.00032	CcSEcCtD
Naltrexone—Body temperature increased—Hydrocortisone—psoriasis	0.000104	0.00032	CcSEcCtD
Naltrexone—Convulsion—Prednisone—psoriasis	0.000104	0.000319	CcSEcCtD
Naltrexone—Mediastinal disorder—Methotrexate—psoriasis	0.000104	0.000319	CcSEcCtD
Naltrexone—Asthenia—Mycophenolate mofetil—psoriasis	0.000104	0.000318	CcSEcCtD
Naltrexone—Hypertension—Prednisone—psoriasis	0.000104	0.000318	CcSEcCtD
Naltrexone—Chills—Methotrexate—psoriasis	0.000103	0.000318	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000103	0.000315	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000103	0.000315	CcSEcCtD
Naltrexone—Pruritus—Mycophenolate mofetil—psoriasis	0.000102	0.000314	CcSEcCtD
Naltrexone—Arthralgia—Prednisone—psoriasis	0.000102	0.000314	CcSEcCtD
Naltrexone—Myalgia—Prednisone—psoriasis	0.000102	0.000314	CcSEcCtD
Naltrexone—Feeling abnormal—Triamcinolone—psoriasis	0.000102	0.000314	CcSEcCtD
Naltrexone—Anxiety—Prednisone—psoriasis	0.000102	0.000313	CcSEcCtD
Naltrexone—Alopecia—Methotrexate—psoriasis	0.000102	0.000313	CcSEcCtD
Naltrexone—Insomnia—Betamethasone—psoriasis	0.000102	0.000312	CcSEcCtD
Naltrexone—Insomnia—Dexamethasone—psoriasis	0.000102	0.000312	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000102	0.000312	CcSEcCtD
Naltrexone—Diarrhoea—Cyclosporine—psoriasis	0.000101	0.000311	CcSEcCtD
Naltrexone—Paraesthesia—Betamethasone—psoriasis	0.000101	0.00031	CcSEcCtD
Naltrexone—Paraesthesia—Dexamethasone—psoriasis	0.000101	0.00031	CcSEcCtD
Naltrexone—Discomfort—Prednisone—psoriasis	0.000101	0.00031	CcSEcCtD
Naltrexone—Mental disorder—Methotrexate—psoriasis	0.000101	0.00031	CcSEcCtD
Naltrexone—Malnutrition—Methotrexate—psoriasis	0.0001	0.000308	CcSEcCtD
Naltrexone—Hypersensitivity—Prednisolone—psoriasis	9.94e-05	0.000305	CcSEcCtD
Naltrexone—Diarrhoea—Mycophenolate mofetil—psoriasis	9.9e-05	0.000304	CcSEcCtD
Naltrexone—Urticaria—Triamcinolone—psoriasis	9.86e-05	0.000302	CcSEcCtD
Naltrexone—Dysgeusia—Methotrexate—psoriasis	9.83e-05	0.000302	CcSEcCtD
Naltrexone—Body temperature increased—Triamcinolone—psoriasis	9.81e-05	0.000301	CcSEcCtD
Naltrexone—Dizziness—Cyclosporine—psoriasis	9.8e-05	0.000301	CcSEcCtD
Naltrexone—Anaphylactic shock—Prednisone—psoriasis	9.8e-05	0.000301	CcSEcCtD
Naltrexone—Oedema—Prednisone—psoriasis	9.8e-05	0.000301	CcSEcCtD
Naltrexone—Decreased appetite—Betamethasone—psoriasis	9.79e-05	0.0003	CcSEcCtD
Naltrexone—Decreased appetite—Dexamethasone—psoriasis	9.79e-05	0.0003	CcSEcCtD
Naltrexone—Infection—Prednisone—psoriasis	9.74e-05	0.000299	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Dexamethasone—psoriasis	9.72e-05	0.000298	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Betamethasone—psoriasis	9.72e-05	0.000298	CcSEcCtD
Naltrexone—Back pain—Methotrexate—psoriasis	9.71e-05	0.000298	CcSEcCtD
Naltrexone—Hypersensitivity—Hydrocortisone—psoriasis	9.71e-05	0.000298	CcSEcCtD
Naltrexone—Fatigue—Dexamethasone—psoriasis	9.71e-05	0.000298	CcSEcCtD
Naltrexone—Fatigue—Betamethasone—psoriasis	9.71e-05	0.000298	CcSEcCtD
Naltrexone—Shock—Prednisone—psoriasis	9.65e-05	0.000296	CcSEcCtD
Naltrexone—Pain—Dexamethasone—psoriasis	9.63e-05	0.000295	CcSEcCtD
Naltrexone—Pain—Betamethasone—psoriasis	9.63e-05	0.000295	CcSEcCtD
Naltrexone—Nervous system disorder—Prednisone—psoriasis	9.61e-05	0.000295	CcSEcCtD
Naltrexone—Tachycardia—Prednisone—psoriasis	9.57e-05	0.000294	CcSEcCtD
Naltrexone—Dizziness—Mycophenolate mofetil—psoriasis	9.56e-05	0.000293	CcSEcCtD
Naltrexone—Skin disorder—Prednisone—psoriasis	9.52e-05	0.000292	CcSEcCtD
Naltrexone—Hyperhidrosis—Prednisone—psoriasis	9.48e-05	0.000291	CcSEcCtD
Naltrexone—Vision blurred—Methotrexate—psoriasis	9.46e-05	0.00029	CcSEcCtD
Naltrexone—Asthenia—Hydrocortisone—psoriasis	9.45e-05	0.00029	CcSEcCtD
Naltrexone—Vomiting—Cyclosporine—psoriasis	9.43e-05	0.000289	CcSEcCtD
Naltrexone—Rash—Cyclosporine—psoriasis	9.35e-05	0.000287	CcSEcCtD
Naltrexone—Anorexia—Prednisone—psoriasis	9.35e-05	0.000287	CcSEcCtD
Naltrexone—Dermatitis—Cyclosporine—psoriasis	9.34e-05	0.000287	CcSEcCtD
Naltrexone—Pruritus—Hydrocortisone—psoriasis	9.32e-05	0.000286	CcSEcCtD
Naltrexone—Ill-defined disorder—Methotrexate—psoriasis	9.32e-05	0.000286	CcSEcCtD
Naltrexone—Headache—Cyclosporine—psoriasis	9.29e-05	0.000285	CcSEcCtD
Naltrexone—Feeling abnormal—Betamethasone—psoriasis	9.28e-05	0.000285	CcSEcCtD
Naltrexone—Feeling abnormal—Dexamethasone—psoriasis	9.28e-05	0.000285	CcSEcCtD
Naltrexone—Gastrointestinal pain—Betamethasone—psoriasis	9.21e-05	0.000282	CcSEcCtD
Naltrexone—Gastrointestinal pain—Dexamethasone—psoriasis	9.21e-05	0.000282	CcSEcCtD
Naltrexone—Vomiting—Mycophenolate mofetil—psoriasis	9.2e-05	0.000282	CcSEcCtD
Naltrexone—Hypersensitivity—Triamcinolone—psoriasis	9.14e-05	0.00028	CcSEcCtD
Naltrexone—Rash—Mycophenolate mofetil—psoriasis	9.12e-05	0.00028	CcSEcCtD
Naltrexone—Dermatitis—Mycophenolate mofetil—psoriasis	9.11e-05	0.00028	CcSEcCtD
Naltrexone—Headache—Mycophenolate mofetil—psoriasis	9.06e-05	0.000278	CcSEcCtD
Naltrexone—Malaise—Methotrexate—psoriasis	9.05e-05	0.000278	CcSEcCtD
Naltrexone—Diarrhoea—Hydrocortisone—psoriasis	9.02e-05	0.000277	CcSEcCtD
Naltrexone—Urticaria—Dexamethasone—psoriasis	8.94e-05	0.000274	CcSEcCtD
Naltrexone—Urticaria—Betamethasone—psoriasis	8.94e-05	0.000274	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Prednisone—psoriasis	8.93e-05	0.000274	CcSEcCtD
Naltrexone—Dizziness—Prednisolone—psoriasis	8.92e-05	0.000274	CcSEcCtD
Naltrexone—Asthenia—Triamcinolone—psoriasis	8.9e-05	0.000273	CcSEcCtD
Naltrexone—Abdominal pain—Betamethasone—psoriasis	8.9e-05	0.000273	CcSEcCtD
Naltrexone—Body temperature increased—Betamethasone—psoriasis	8.9e-05	0.000273	CcSEcCtD
Naltrexone—Body temperature increased—Dexamethasone—psoriasis	8.9e-05	0.000273	CcSEcCtD
Naltrexone—Abdominal pain—Dexamethasone—psoriasis	8.9e-05	0.000273	CcSEcCtD
Naltrexone—Insomnia—Prednisone—psoriasis	8.87e-05	0.000272	CcSEcCtD
Naltrexone—Nausea—Cyclosporine—psoriasis	8.81e-05	0.00027	CcSEcCtD
Naltrexone—Paraesthesia—Prednisone—psoriasis	8.8e-05	0.00027	CcSEcCtD
Naltrexone—Pruritus—Triamcinolone—psoriasis	8.78e-05	0.000269	CcSEcCtD
Naltrexone—Cough—Methotrexate—psoriasis	8.76e-05	0.000269	CcSEcCtD
Naltrexone—Dizziness—Hydrocortisone—psoriasis	8.71e-05	0.000267	CcSEcCtD
Naltrexone—Convulsion—Methotrexate—psoriasis	8.7e-05	0.000267	CcSEcCtD
Naltrexone—Nausea—Mycophenolate mofetil—psoriasis	8.59e-05	0.000264	CcSEcCtD
Naltrexone—Chest pain—Methotrexate—psoriasis	8.55e-05	0.000262	CcSEcCtD
Naltrexone—Arthralgia—Methotrexate—psoriasis	8.55e-05	0.000262	CcSEcCtD
Naltrexone—Myalgia—Methotrexate—psoriasis	8.55e-05	0.000262	CcSEcCtD
Naltrexone—Decreased appetite—Prednisone—psoriasis	8.52e-05	0.000261	CcSEcCtD
Naltrexone—Rash—Prednisolone—psoriasis	8.51e-05	0.000261	CcSEcCtD
Naltrexone—Dermatitis—Prednisolone—psoriasis	8.5e-05	0.000261	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	8.49e-05	0.00026	CcSEcCtD
Naltrexone—Fatigue—Prednisone—psoriasis	8.45e-05	0.000259	CcSEcCtD
Naltrexone—Headache—Prednisolone—psoriasis	8.45e-05	0.000259	CcSEcCtD
Naltrexone—Discomfort—Methotrexate—psoriasis	8.45e-05	0.000259	CcSEcCtD
Naltrexone—Constipation—Prednisone—psoriasis	8.38e-05	0.000257	CcSEcCtD
Naltrexone—Vomiting—Hydrocortisone—psoriasis	8.38e-05	0.000257	CcSEcCtD
Naltrexone—Rash—Hydrocortisone—psoriasis	8.31e-05	0.000255	CcSEcCtD
Naltrexone—Dermatitis—Hydrocortisone—psoriasis	8.3e-05	0.000255	CcSEcCtD
Naltrexone—Confusional state—Methotrexate—psoriasis	8.26e-05	0.000253	CcSEcCtD
Naltrexone—Headache—Hydrocortisone—psoriasis	8.26e-05	0.000253	CcSEcCtD
Naltrexone—Dizziness—Triamcinolone—psoriasis	8.2e-05	0.000252	CcSEcCtD
Naltrexone—Anaphylactic shock—Methotrexate—psoriasis	8.19e-05	0.000251	CcSEcCtD
Naltrexone—Infection—Methotrexate—psoriasis	8.14e-05	0.00025	CcSEcCtD
Naltrexone—Feeling abnormal—Prednisone—psoriasis	8.08e-05	0.000248	CcSEcCtD
Naltrexone—Asthenia—Dexamethasone—psoriasis	8.08e-05	0.000248	CcSEcCtD
Naltrexone—Asthenia—Betamethasone—psoriasis	8.08e-05	0.000248	CcSEcCtD
Naltrexone—Nervous system disorder—Methotrexate—psoriasis	8.04e-05	0.000247	CcSEcCtD
Naltrexone—Gastrointestinal pain—Prednisone—psoriasis	8.02e-05	0.000246	CcSEcCtD
Naltrexone—Nausea—Prednisolone—psoriasis	8.01e-05	0.000246	CcSEcCtD
Naltrexone—Pruritus—Dexamethasone—psoriasis	7.97e-05	0.000244	CcSEcCtD
Naltrexone—Pruritus—Betamethasone—psoriasis	7.97e-05	0.000244	CcSEcCtD
Naltrexone—Skin disorder—Methotrexate—psoriasis	7.96e-05	0.000244	CcSEcCtD
Naltrexone—Hyperhidrosis—Methotrexate—psoriasis	7.92e-05	0.000243	CcSEcCtD
Naltrexone—Vomiting—Triamcinolone—psoriasis	7.89e-05	0.000242	CcSEcCtD
Naltrexone—Nausea—Hydrocortisone—psoriasis	7.83e-05	0.00024	CcSEcCtD
Naltrexone—Rash—Triamcinolone—psoriasis	7.82e-05	0.00024	CcSEcCtD
Naltrexone—Dermatitis—Triamcinolone—psoriasis	7.82e-05	0.00024	CcSEcCtD
Naltrexone—Anorexia—Methotrexate—psoriasis	7.81e-05	0.00024	CcSEcCtD
Naltrexone—Urticaria—Prednisone—psoriasis	7.79e-05	0.000239	CcSEcCtD
Naltrexone—Headache—Triamcinolone—psoriasis	7.77e-05	0.000238	CcSEcCtD
Naltrexone—Abdominal pain—Prednisone—psoriasis	7.75e-05	0.000238	CcSEcCtD
Naltrexone—Body temperature increased—Prednisone—psoriasis	7.75e-05	0.000238	CcSEcCtD
Naltrexone—Diarrhoea—Betamethasone—psoriasis	7.7e-05	0.000236	CcSEcCtD
Naltrexone—Diarrhoea—Dexamethasone—psoriasis	7.7e-05	0.000236	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Methotrexate—psoriasis	7.47e-05	0.000229	CcSEcCtD
Naltrexone—Dizziness—Dexamethasone—psoriasis	7.44e-05	0.000228	CcSEcCtD
Naltrexone—Dizziness—Betamethasone—psoriasis	7.44e-05	0.000228	CcSEcCtD
Naltrexone—Insomnia—Methotrexate—psoriasis	7.41e-05	0.000227	CcSEcCtD
Naltrexone—Nausea—Triamcinolone—psoriasis	7.37e-05	0.000226	CcSEcCtD
Naltrexone—Paraesthesia—Methotrexate—psoriasis	7.36e-05	0.000226	CcSEcCtD
Naltrexone—Dyspnoea—Methotrexate—psoriasis	7.31e-05	0.000224	CcSEcCtD
Naltrexone—Somnolence—Methotrexate—psoriasis	7.28e-05	0.000223	CcSEcCtD
Naltrexone—Hypersensitivity—Prednisone—psoriasis	7.22e-05	0.000222	CcSEcCtD
Naltrexone—Vomiting—Betamethasone—psoriasis	7.16e-05	0.00022	CcSEcCtD
Naltrexone—Vomiting—Dexamethasone—psoriasis	7.16e-05	0.00022	CcSEcCtD
Naltrexone—Decreased appetite—Methotrexate—psoriasis	7.12e-05	0.000219	CcSEcCtD
Naltrexone—Rash—Betamethasone—psoriasis	7.1e-05	0.000218	CcSEcCtD
Naltrexone—Rash—Dexamethasone—psoriasis	7.1e-05	0.000218	CcSEcCtD
Naltrexone—Dermatitis—Betamethasone—psoriasis	7.09e-05	0.000218	CcSEcCtD
Naltrexone—Dermatitis—Dexamethasone—psoriasis	7.09e-05	0.000218	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Methotrexate—psoriasis	7.07e-05	0.000217	CcSEcCtD
Naltrexone—Fatigue—Methotrexate—psoriasis	7.06e-05	0.000217	CcSEcCtD
Naltrexone—Headache—Dexamethasone—psoriasis	7.05e-05	0.000216	CcSEcCtD
Naltrexone—Headache—Betamethasone—psoriasis	7.05e-05	0.000216	CcSEcCtD
Naltrexone—Asthenia—Prednisone—psoriasis	7.03e-05	0.000216	CcSEcCtD
Naltrexone—Pain—Methotrexate—psoriasis	7.01e-05	0.000215	CcSEcCtD
Naltrexone—Pruritus—Prednisone—psoriasis	6.94e-05	0.000213	CcSEcCtD
Naltrexone—Feeling abnormal—Methotrexate—psoriasis	6.75e-05	0.000207	CcSEcCtD
Naltrexone—Diarrhoea—Prednisone—psoriasis	6.71e-05	0.000206	CcSEcCtD
Naltrexone—Gastrointestinal pain—Methotrexate—psoriasis	6.7e-05	0.000206	CcSEcCtD
Naltrexone—Nausea—Dexamethasone—psoriasis	6.69e-05	0.000205	CcSEcCtD
Naltrexone—Nausea—Betamethasone—psoriasis	6.69e-05	0.000205	CcSEcCtD
Naltrexone—Urticaria—Methotrexate—psoriasis	6.51e-05	0.0002	CcSEcCtD
Naltrexone—Dizziness—Prednisone—psoriasis	6.48e-05	0.000199	CcSEcCtD
Naltrexone—Body temperature increased—Methotrexate—psoriasis	6.48e-05	0.000199	CcSEcCtD
Naltrexone—Abdominal pain—Methotrexate—psoriasis	6.48e-05	0.000199	CcSEcCtD
Naltrexone—Vomiting—Prednisone—psoriasis	6.23e-05	0.000191	CcSEcCtD
Naltrexone—Rash—Prednisone—psoriasis	6.18e-05	0.00019	CcSEcCtD
Naltrexone—Dermatitis—Prednisone—psoriasis	6.18e-05	0.000189	CcSEcCtD
Naltrexone—Headache—Prednisone—psoriasis	6.14e-05	0.000188	CcSEcCtD
Naltrexone—Hypersensitivity—Methotrexate—psoriasis	6.04e-05	0.000185	CcSEcCtD
Naltrexone—Asthenia—Methotrexate—psoriasis	5.88e-05	0.00018	CcSEcCtD
Naltrexone—Nausea—Prednisone—psoriasis	5.82e-05	0.000179	CcSEcCtD
Naltrexone—Pruritus—Methotrexate—psoriasis	5.8e-05	0.000178	CcSEcCtD
Naltrexone—Diarrhoea—Methotrexate—psoriasis	5.61e-05	0.000172	CcSEcCtD
Naltrexone—Dizziness—Methotrexate—psoriasis	5.42e-05	0.000166	CcSEcCtD
Naltrexone—Vomiting—Methotrexate—psoriasis	5.21e-05	0.00016	CcSEcCtD
Naltrexone—Rash—Methotrexate—psoriasis	5.17e-05	0.000159	CcSEcCtD
Naltrexone—Dermatitis—Methotrexate—psoriasis	5.16e-05	0.000158	CcSEcCtD
Naltrexone—Headache—Methotrexate—psoriasis	5.13e-05	0.000157	CcSEcCtD
Naltrexone—Nausea—Methotrexate—psoriasis	4.87e-05	0.000149	CcSEcCtD
